Descriptor English: | Interferon beta-1b | ||||
Descriptor Spanish: |
Interferon beta-1b
| ||||
Descriptor Portuguese: | Interferon beta-1b | ||||
Descriptor French: | Interféron bêta-1b | ||||
Entry term(s): |
Beta Seron Beta-IFN-1b Beta-Seron Betaferon Betaseron Extavia IFN-Beta Ser Interferon Beta, Ser(17) Interferon Beta, Serine(17) Interferon beta 1b Ser(17) IFN-beta Serine(17) Interferon Beta |
||||
Tree number(s): |
D12.644.276.374.440.890.275.750 D12.776.467.374.440.890.275.750 D23.529.374.440.890.275.750 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068576 | ||||
Scope note: | A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS. |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Pharm Action: |
Adjuvants, Immunologic |
||||
Registry Number: | 145155-23-3 | ||||
Public MeSH Note: | 2016; INTERFERON BETA-1B was previously indexed under INTERFERON BETA, 1991-2015; RECOMBINANT PROTEINS, 1988-1991; and under INTERFERON TYPE I, 1985-1988 |
||||
History Note: | 2016 (1985) |
||||
DeCS ID: | 55970 | ||||
Unique ID: | D000068576 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/01 | ||||
Revision Date: | 2017/12/14 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Interferon beta-1b
- Preferred
Betaseron
- Narrower
Extavia
- Narrower
Betaferon
- Narrower
Concept UI |
M0129586 |
Scope note | A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS. |
Preferred term | Interferon beta-1b |
Entry term(s) |
Beta-IFN-1b IFN-Beta Ser Interferon Beta, Ser(17) Interferon Beta, Serine(17) Interferon beta 1b Ser(17) IFN-beta Serine(17) Interferon Beta |
Concept UI |
M0129576 |
Preferred term | Betaseron |
Entry term(s) |
Beta Seron Beta-Seron |
Concept UI |
M0552159 |
Preferred term | Extavia |
Concept UI |
M0556963 |
Preferred term | Betaferon |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey